Indolent Nodal Relapse of Colon Carcinoma with Associated Tumor Thrombus Invading the Superior Mesenteric Vein

  • Megan Greally
  • Keith Pilson
  • Anna Linehan
  • Conor O’Keane
  • Conor J. Shields
  • John B. Conneely
  • John A. McCaffrey
Case Report


Approximately 50–60% of patients with colorectal cancer develop metastatic disease, with the liver, lungs, and peritoneum being the commonest sites of occurrence. While there is data supporting the role of metastatectomy for liver disease, especially when occurring metachronously, evidence is limited for resection of extrahepatic disease. However, there is some evidence that judicious use of salvage surgery has a role in well-selected patients. This case highlights the extremely rare diagnosis of superior mesenteric vein (SMV) tumor thrombus related to metastatic nodal recurrence of colon cancer in a 54-year-old male with a history of T3N2b colon cancer. We present the diagnostic and management issues associated with this complex case which demonstrated an unusual pattern of recurrence.

Case Report

A 54-year-old gentleman who, during active surveillance for a low-grade Gleason 3+3 prostate cancer diagnosed in 2012, complained of progressive colicky left iliac fossa and...


Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.


  1. 1.
    Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. Scholar
  2. 2.
    Edge S, Byrd DR, Compton CC, Fritz AG, Greene F, Trotti A. AJCC (American Joint Committee on Cancer) cancer staging manual. 7th ed. New York: Springer; 2010.Google Scholar
  3. 3.
    Booth CM, Nanji S, Wei X, Peng Y, Biagi JJ, Hanna TP, et al. Use and effectiveness of adjuvant chemotherapy for stage III colon cancer: a population-based study. J Nat Comp Cancer Net: JNCCN. 2016;14(1):47–56.CrossRefGoogle Scholar
  4. 4.
    Andre T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol: Off J Am Soc Clin Oncol. 2009;27(19):3109–16. Scholar
  5. 5.
    Bockelman C, Engelmann BE, Kaprio T, Hansen TF, Glimelius B. Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature. Acta Oncol. 2015;54(1):5–16. Scholar
  6. 6.
    Cummings LC, Payes JD, Cooper GS. Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer. 2007;109(4):718–26. Scholar
  7. 7.
    Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg. 2008;247(1):125–35. Scholar
  8. 8.
    Morris EJ, Forman D, Thomas JD, Quirke P, Taylor EF, Fairley L, et al. Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg. 2010;97(7):1110–8. Scholar
  9. 9.
    Primrose JN, Perera R, Gray A, Rose P, Fuller A, Corkhill A, et al. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA. 2014;311(3):263–70. Scholar
  10. 10.
    Pita-Fernandez S, Alhayek-Ai M, Gonzalez-Martin C, Lopez-Calvino B, Seoane-Pillado T, Pertega-Diaz S. Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis. Ann Oncol: Off J Eur Soc Med Oncol. 2015;26(4):644–56. Scholar
  11. 11.
    Guyot F, Faivre J, Manfredi S, Meny B, Bonithon-Kopp C, Bouvier AM. Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol: Off J Eur Soc Med Oncol. 2005;16(5):756–61. Scholar
  12. 12.
    Goldberg RM, Fleming TR, Tangen CM, Moertel CG, Macdonald JS, Haller DG, et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med. 1998;129(1):27–35.CrossRefPubMedGoogle Scholar
  13. 13.
    Meyers D, Nixon NA, Franko A, Ng D, Tam VC. Tumour thrombus of the inferior vena cava extending into the right atrium in the setting of colon cancer. BMJ Case Rep. 2017;2017
  14. 14.
    Kaida H, Ishibashi M, Kurata S, Uchida M, Hayabuchi N. Tumor thrombus in the inferior vena cava from colon cancer detected by 18F-FDG-PET. Ann Nucl Med. 2007;21(3):185–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Matsumura A, Hatakeyama T, Ogino S, Takemura M, Mugitani T, Akami T, et al. Two cases of colorectal cancer with tumor thrombus in the inferior mesenteric vein. Gan to kagaku ryoho Cancer Chemother. 2015;42(12):2224–6.Google Scholar
  16. 16.
    Otani K, Ishihara S, Hata K, Murono K, Sasaki K, Yasuda K, et al. Colorectal cancer with venous tumor thrombosis. Asian J Surger. 2016;
  17. 17.
    Izumi R, Shimizu K, Ii T, Yagi M, Matsui O, Nonomura A, et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology. 1994;106(3):720–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Reese AC, Whitson JM, Meng MV. Natural history of untreated renal cell carcinoma with venous tumor thrombus. Urol Oncol. 2013;31(7):1305–9. Scholar
  19. 19.
    Jia L, Kiryu S, Watadani T, Akai H, Yamashita H, Akahane M, et al. Prognosis of hepatocellular carcinoma with portal vein tumor thrombus: assessment based on clinical and computer tomography characteristics. Acta Med Okayama. 2012;66(2):131–41. Scholar
  20. 20.
    Lai P, Bomanji JB, Mahmood S, Nagabhushan N, Syed R, Gacinovic S, et al. Detection of tumour thrombus by 18F-FDG-PET/CT imaging. Eur J Cancer Preven: Off J Eur Cancer Preven Org. 2007;16(1):90–4. Scholar
  21. 21.
    Gupta P, Kramer EL, Ponzo F. FDG uptake in tumor thrombus in inferior vena cava from rectal cancer on positron emission tomography. Clin Nucl Med. 2005;30(5):342–3.CrossRefPubMedGoogle Scholar
  22. 22.
    Davidson T, Goitein O, Avigdor A, Zwas ST, Goshen E. 18F- FDG-PET/CT for the diagnosis of tumor thrombosis. Israel Med Assoc J: IMAJ. 2009;11(2):69–73.Google Scholar
  23. 23.
    Sharma P, Kumar R, Jeph S, Karunanithi S, Naswa N, Gupta A, et al. 18F-FDG PET-CT in the diagnosis of tumor thrombus: can it be differentiated from benign thrombus? Nucl Med Commun. 2011;32(9):782–8. Scholar
  24. 24.
    Mudalsha R, Jacob M, Pandit A, Jora C. Extensive tumor thrombus in a case of carcinoma lung detected by F18-FDG-PET/CT. Ind J Nuclear Med: IJNM: Off J Soc Nuclear Med Ind. 2011;26(2):117–9. Scholar
  25. 25.
    Nissan A, Guillem JG, Paty PB, Wong WD, Cohen AM. Signet-ring cell carcinoma of the colon and rectum: a matched control study. Dis Colon rectum. 1999;42(9):1176–80.CrossRefPubMedGoogle Scholar
  26. 26.
    Psathakis D, Schiedeck TH, Krug F, Oevermann E, Kujath P, Bruch HP. Ordinary colorectal adenocarcinoma vs. primary colorectal signet-ring cell carcinoma: study matched for age, gender, grade, and stage. Dis Colon rectum. 1999;42(12):1618–25.CrossRefPubMedGoogle Scholar
  27. 27.
    Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg. 1996;224(4):509–20. discussion 520-502CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg. 2004;240(3):438–447; discussion 447-450.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg. 2007;84(1):324–38. Scholar
  30. 30.
    Shibata D, Paty PB, Guillem JG, Wong WD, Cohen AM. Surgical management of isolated retroperitoneal recurrences of colorectal carcinoma. Dis Colon rectum. 2002;45(6):795–801.CrossRefPubMedGoogle Scholar
  31. 31.
    Bowne WB, Lee B, Wong WD, Ben-Porat L, Shia J, Cohen AM, et al. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases. Dis Colon rectum. 2005;48(5):897–909. Scholar
  32. 32.
    Min BS, Kim NK, Sohn SK, Cho CH, Lee KY, Baik SH. Isolated paraaortic lymph-node recurrence after the curative resection of colorectal carcinoma. J Surg Oncol. 2008;97(2):136–40. Scholar
  33. 33.
    Lefevre JH, Rondelli F, Mourra N, Bennis M, Tiret E, Parc R, et al. Lumboaortic and iliac lymphadenectomy for lymph node recurrence of colorectal cancer: prognostic value of the MSI phenotype. Ann Surg Oncol. 2008;15(9):2433–8. Scholar
  34. 34.
    Takeshima K, Yamafuji K, Asami A, Baba H, Okamoto N, Takahashi H, et al. Successful resection of isolated para-aortic lymph node recurrence from advanced sigmoid colon cancer following 156 courses of FOLFIRI regimen. Case Rep Surger. 2016;2016(4548798):1–5. Scholar
  35. 35.
    Mitry E, Fields AL, Bleiberg H, Labianca R, Portier G, Tu D, et al. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol: Off J Am Soc Clin Oncol. 2008;26(30):4906–11. Scholar
  36. 36.
    Ychou M, Hohenberger W, Thezenas S, Navarro M, Maurel J, Bokemeyer C, et al. A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer. Ann Oncol: Off J Eur Soc Med Oncol. 2009;20(12):1964–70. Scholar
  37. 37.
    Tournigand C, Andre T, Achille E, Lledo G, Flesh M, Mery-Mignard D, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol: Off J Am Soc Clin Oncol. 2004;22(2):229–37. Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Mater Misericordiae University HospitalDublin 7Ireland
  2. 2.Gastrointestinal Oncology, Department of MedicineMemorial Sloan Kettering Cancer CenterNew YorkUSA

Personalised recommendations